1 report

  • 09/21/2017: BIOCRYSTS RAPIVAB (PERAMIVIR INJECTION) RECEIVES FDA APPROVAL FOR A PEDIATRIC INDICATION

" This approval represents the first new influenza antiviral for pediatric use in over ## years, " said Jon P.

  • Influenza Antiviral
  • Pharmaceutical
  • Therapy
  • United States
  • BioCryst Pharmaceuticals, Inc.